Haemophilia Society of Singapore
There are over 200 peoplein Singapore diagnosed with variations of haemophilia, a genetic blood-clotting disorder.
According to the Haemophilia Society of Singapore (HSS), a haemophilia patient spends, on average, $3,000 to $4,000 a month on regular infusions of clotting factor to prevent spontaneous bleeding.
Patients typically receive a 50 to 65 per cent government subsidy and HSS members get an extra 20 to 25 per cent subsidy. With the subsidies, the treatment costs about half the usual price.
The nonprofit society, established in 1985, spends about $130,000 to $150,000 a year, mainly on medication subsidies for its members.
To donate to HSS, log onto the Haemophilia Society of Singapore's website at haemophilia.org.sg or e-mail firstname.lastname@example.org.